{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:10:28Z","timestamp":1788905428852,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,20]],"date-time":"2027-07-20T00:00:00Z","timestamp":1816041600000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaut.2026.103597","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:14:22Z","timestamp":1784567662000},"page":"103597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immunomodulatory effects of tacrolimus-loaded lipid-core nanocapsules in autoimmune hepatitis"],"prefix":"10.1016","volume":"163","author":[{"given":"Graziela S.","family":"Gomes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cortney","family":"Cagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Visioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du Hanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sruthika","family":"Macha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Csizmadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Bonder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilas","family":"Patwardhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia S.","family":"Guterres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana R.","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza A.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-1249","authenticated-orcid":false,"given":"Maria Serena","family":"Longhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2026.103597_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2026.103597_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-021-08888-9","article-title":"Autoimmune hepatitis: serum autoantibodies in clinical practice","volume":"63","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2026.103597_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/apt.15111","article-title":"Review article: unanswered clinical and research questions in autoimmune hepatitis-conclusions of the International Autoimmune Hepatitis Group Research Workshop","volume":"49","author":"Dyson","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2026.103597_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11684-015-0386-y","article-title":"Autoimmune hepatitis","volume":"9","author":"Sahebjam","year":"2015","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2026.103597_bib5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2026.103597_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183776","article-title":"Clonal analysis of SepSecS-specific B and T cells in autoimmune hepatitis","volume":"135","author":"Kramer","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2026.103597_bib7","article-title":"Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103597_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103597_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103597_bib10","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2026.103597_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103597_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103597_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103597_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.mpg.0000235975.75120.38","article-title":"Follow-up of children with autoimmune hepatitis treated with cyclosporine","volume":"43","author":"Cuarterolo","year":"2006","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2026.103597_bib15","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2026.103597_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of Autoimmune Hepatitis in adults and children: 2019 Practice Guidance and Guidelines from the American Association for the Study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2026.103597_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060784","article-title":"Tacrolimus inhibits NF-kappaB activation in peripheral human T cells","volume":"8","author":"Vafadari","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2026.103597_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00467-018-3892-8","article-title":"Clinical aspects of tacrolimus use in paediatric renal transplant recipients","volume":"34","author":"Prytula","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.jaut.2026.103597_bib19","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1166\/jbn.2014.1842","article-title":"Nanoencapsulation of tacrolimus in lipid-core nanocapsules showed similar immunosuppressive activity after oral and intraperitoneal administrations","volume":"10","author":"Friedrich","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jaut.2026.103597_bib20","doi-asserted-by":"crossref","first-page":"18262","DOI":"10.1002\/jcp.28458","article-title":"Targeted delivery of tacrolimus to T cells by pH-responsive aptamer-chitosan- poly(lactic-co-glycolic acid) nanocomplex","volume":"234","author":"Mansouri","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jaut.2026.103597_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13122013","article-title":"Characterization and in vitro and in vivo evaluation of tacrolimus-loaded Poly(epsilon-Caprolactone) nanocapsules for the management of atopic dermatitis","volume":"13","author":"Camargo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jaut.2026.103597_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12951-021-00857-w","article-title":"Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis","volume":"19","author":"Kim","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jaut.2026.103597_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122535","article-title":"Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis","volume":"631","author":"Gomes","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jaut.2026.103597_bib24","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1039\/c2sm25754h","article-title":"Lipid-core nanocapsules: mechanism of self-assembly, control of size and loading capacity","volume":"8","author":"Jornada","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.jaut.2026.103597_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103162","article-title":"Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis","volume":"143","author":"Gao","year":"2024","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103597_bib26","article-title":"Inhibition of estrogen receptor alpha stabilizes regulatory T cell function in autoimmune hepatitis","volume":"8","author":"Zhang","year":"2026","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jaut.2026.103597_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92791","article-title":"Bilirubin suppresses Th17 immunity in colitis by upregulating CD39","volume":"2","author":"Longhi","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2026.103597_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/labinvest.3700219","article-title":"Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique","volume":"85","author":"Morsy","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jaut.2026.103597_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaut.2016.05.005","article-title":"CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease","volume":"72","author":"Liberal","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103597_bib30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.chom.2022.05.006","article-title":"Tet2 deficiency drives liver microbiome dysbiosis triggering Tc1 cell autoimmune hepatitis","volume":"30","author":"Pandey","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaut.2026.103597_bib31","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2026.103597_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2020.06.044","article-title":"Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis","volume":"74","author":"Vuerich","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103597_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/nano10091649","article-title":"Biocompatibility of biomaterials for nanoencapsulation: current approaches","volume":"10","author":"Witika","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jaut.2026.103597_bib34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(reg) cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2026.103597_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2026.103597_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/cei.12956","article-title":"Immunosuppressive drugs affect interferon (IFN)-gamma and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis","volume":"189","author":"Grant","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2026.103597_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103591","article-title":"B and T cells: (still) the dominant orchestrators in autoimmune hepatitis","volume":"23","author":"Longhi","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2026.103597_bib38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.31739","article-title":"The clinical significance of Hepatic CD69(+) CD103(+) CD8(+) resident-memory T cells in autoimmune hepatitis","volume":"74","author":"You","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2026.103597_bib39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2023.05.020","article-title":"Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination reveals distinct characteristics","volume":"79","author":"Uzun","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103597_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2026.02.026","article-title":"Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis","author":"Xu","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2026.103597_bib41","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.4049\/jimmunol.1600228","article-title":"Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis","volume":"197","author":"Gil-Farina","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2026.103597_bib42","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/hep.27998","article-title":"A novel \"humanized mouse\" model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","volume":"62","author":"Yuksel","year":"2015","journal-title":"Hepatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:56:26Z","timestamp":1788904586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S0896841126000752"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103597","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory effects of tacrolimus-loaded lipid-core nanocapsules in autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103597"}}